Cargando…
SGLT2 Inhibitors: A Review of Their Antidiabetic and Cardioprotective Effects
Type 2 diabetes mellitus is a chronic metabolic disease associated with high cardiovascular (CV) risk. Sodium-glucose co-transporter 2 inhibitors (SGLT2i) are the latest class of antidiabetic medication that inhibit the absorption of glucose from the proximal tubule of the kidney and hence cause gly...
Autores principales: | Tentolouris, Anastasios, Vlachakis, Panayotis, Tzeravini, Evangelia, Eleftheriadou, Ioanna, Tentolouris, Nikolaos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6720282/ https://www.ncbi.nlm.nih.gov/pubmed/31426529 http://dx.doi.org/10.3390/ijerph16162965 |
Ejemplares similares
-
The Role of Diabetes and Hyperglycemia on COVID-19 Infection Course—A Narrative Review
por: Tzeravini, Evangelia, et al.
Publicado: (2022) -
Current data on the cardiovascular effects of COVID-19
por: Vlachakis, Panayotis K., et al.
Publicado: (2020) -
Immunogenicity of SARS-CoV-2 BNT162b2 Vaccine in People with Diabetes: A Prospective Observational Study
por: Papadokostaki, Eleni, et al.
Publicado: (2022) -
Clinical Management of Diabetes Mellitus in the Era of COVID-19: Practical Issues, Peculiarities and Concerns
por: Koliaki, Chrysi, et al.
Publicado: (2020) -
Concerns for management of STEMI patients in the COVID-19 era: a paradox phenomenon
por: Vlachakis, Panayotis K., et al.
Publicado: (2020)